We showed that an unrelated secondary adenovirus infection following a primary Semliki Forest virus (SFV) infection fails to trigger partial lymphocyte activation for a duration of 5–9 days post-primary infection due to IFN-I exhaustion Y-27632 price [16]. We found that IFN-I levels are below the detection limit at day 1 after a secondary viral infection, and the hosts regain its capacity to mount IFN-I responses 9 or more

days after a primary viral infection. Thus, it is likely that IFN-I exhaustion is responsible for the heightened susceptibility to secondary viral infections. Co-infection models examining synergistic consequences between respiratory pathogens are click here predominantly concerned with combinations of viral and bacterial pathogens. This is largely due to information gained from the devastating Spanish influenza pandemic of 1918 when the majority of deaths were due to bacterial co-infections or subsequent bacterial infections [22, 23]. In the case of the 2009 Swine

flu pandemic, 18~34% of influenza episodes admitted to intensive care units worldwide were due to complications caused by bacterial co-infections [24-29]. Of these cases, Staphylococcus aureus and Streptococcus pneumoniae were the most commonly isolated bacterial pathogens. These pathogens colonize the upper respiratory tract and nasopharyngeal cavity [30, 31], and it has therefore been hypothesized that influenza infections allow outgrowth of colonized S. pneumoniae or S. aureus and result in mucosal co-infections [32-34]. Such secondary infections occur most frequently at 5–10 days after primary

viral infections, thus suggesting that a transient immunosuppression may be responsible for the bacterial outgrowth. A mechanism proposed for a synergism between influenza and S. pneumoniae suggests that the antiviral IFN-I response elicited by the primary influenza virus infection enhances the susceptibility of the host to secondary bacterial challenge via suppression of antibacterial immunity [34-36]. Recent mathematical modelling 4-Aminobutyrate aminotransferase of epidemiological data from the 1918 influenza pandemic has shown a positive correlation between Mycobacterium tuberculosis and influenza death [37]. M. tuberculosis is a clinically important bacterial pathogen that latently infects one-third of the world’s population. Negative effects of IFN-I during M. Tuberculosis infection have repeatedly been shown [38-41]. However, with an exception of highly virulent strains [40], M. tuberculosis does not generally induce strong IFN-I responses [42] despite possessing a Toll-like receptor (TLR)-9 agonist (DNA-containing CpG motifs), which is a potent IFN-I inducer.